Telehealth Recordings

New Therapies for Hepatitis C

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • Other: 0.75
  • Cost: Free
  • Release: Jun 3, 2015
  • Expires: Jun 3, 2018
  • Estimated Time to Complete:
    45 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Derek W.  Forster Derek W. Forster, MD
Assistant Professor, Medicine
University of Kentucky College of Medicine
Clinical Provider
Bluegrass Care Clinic
Medical Director
Infection Prevention & Control
UKHealthCare
Lexington, Kentucky

Needs Statement

Hepatitis C is prevalent in Kentucky with some of the highest incidence rates in the country. Many patients are in underserved areas with limited access to care. Increasing the availability of care providers with knowledge of Hepatitis C and its treatments is key to improving care of these patients and the region.

Target Audience

Primary care providers, nurses, social workers, and pharmacists.

Objectives

Upon completion of this educational activity, participants will be able to:

  • Describe currently available therapies for Hepatitis C
  • Review indications for therapy
  • Apply treatment recommendations in a case-based format

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Medical knowledge

IOM Competencies

  • Provide patient-centered care

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

Faculty Disclosure

No speaker or planners have any relevant financial relationships to disclose.
 
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
 
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with Southern Central AIDS Education Telehealth Training Center.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.